Tag - JNP

Markets

Roth doubles Juniper Pharma PT to $24

Roth Capital Partners doubled its price target for Juniper Pharmaceuticals (NASDAQ:JNP) to $24 from $12 after the company reported 2017 results. The stock closed at $10 on March 9. Juniper is focused on developing...

March 9, 2018

Feature

Juniper Pharma’s lidocaine vaginal gel data due in Q3

By Len Zehr Juniper Pharmaceuticals (NASDAQ:JNP) expects to report results in the third quarter from a Phase 2b clinical trial of its 10% lidocaine bioadhesive vaginal gel, COL-1077, a local anesthetic for pain from...

June 28, 2016

Tag - JNP

Roth doubles Juniper Pharma PT to $24

Juniper Pharma’s lidocaine vaginal gel data due in Q3

General

More